Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Surufatinib”

110 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 110 results

Testing effectiveness (Phase 2)UnknownNCT04955886
What this trial is testing

Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 14
Not applicableNot Yet RecruitingNCT07780539
What this trial is testing

Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine (NE) Tumors
Yefeng 60
Early research (Phase 1)Study completedNCT04755075
What this trial is testing

Surufatinib Hepatic Impairment Study

Who this might be right for
Hepatic Impairment
Hutchison Medipharma Limited 16
Not applicableUnknownNCT05013515
What this trial is testing

Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland Carcinomas

Who this might be right for
Salivary Gland Carcinomas
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 20
Testing effectiveness (Phase 2)Study completedNCT05077384
What this trial is testing

Open-label Study of Surufatinib in Japanese Patients

Who this might be right for
Neuroendocrine TumorsNon-hematologic Malignancy
Hutchmed 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04922658
What this trial is testing

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 76
Testing effectiveness (Phase 2)Looking for participantsNCT07609121
What this trial is testing

Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Sun Yat-sen University 160
Testing effectiveness (Phase 2)Study completedNCT05494580
What this trial is testing

Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian CarcinomaPlatinum-resistant Ovarian Cancer+2 more
Sun Yat-sen University 29
Testing effectiveness (Phase 2)UnknownNCT04653480
What this trial is testing

Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

Who this might be right for
Colorectal Cancer
Zhejiang University 61
Testing effectiveness (Phase 2)Study completedNCT02614495
What this trial is testing

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
Hutchison Medipharma Limited 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06414915
What this trial is testing

Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation

Who this might be right for
NSCLC
National Cancer Center, China 29
Testing effectiveness (Phase 2)Looking for participantsNCT05747729
What this trial is testing

A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.

Who this might be right for
Neuroendocrine Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05106777
What this trial is testing

Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 47
Large-scale testing (Phase 3)Looking for participantsNCT06361888
What this trial is testing

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Hutchmed 502
Testing effectiveness (Phase 2)Looking for participantsNCT07086469
What this trial is testing

Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
ToripalimabSurufatinibNeoadjuvant Immunochemotherapy+2 more
Sun Yat-sen University 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05590572
What this trial is testing

Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Who this might be right for
Osteosarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 148
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06062485
What this trial is testing

Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma

Who this might be right for
Ampullary Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Early research (Phase 1)Study completedNCT03483259
What this trial is testing

To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers

Who this might be right for
Relative Bioavailability
Hutchison Medipharma Limited 30
Testing effectiveness (Phase 2)Looking for participantsNCT06038461
What this trial is testing

An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Not applicableActive Not RecruitingNCT07534371
What this trial is testing

Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study

Who this might be right for
Neuroendocrine Tumors
West China Hospital 500
Next Page